Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/27/25 17:00 | 2/25/25 | CGEM | Health | BioPrd | Biological Products, (No Diag | Jones Jeffrey Alan | MA | O | Chief Me | 2 | S | -95 | 9.93 | 0 | -10 | 174 | D | |||||||||||||||
2/27/25 17:00 | 2/25/25 | CGEM | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | 2 | S | -207 | 9.87 | 0 | -21 | 431 | D | |||||||||||||||
2/27/25 17:00 | 2/25/25 | CGEM | Health | BioPrd | Biological Products, (No Diag | Michaelson Jennifer | MA | O | Chief Sc | 7 | S | -580 | 14.52 | 0 | -40 | 142 | D | |||||||||||||||
2/27/25 17:00 | 2/25/25 | CGEM | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | 2 | S | -72 | 9.92 | 0 | -7 | 137 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |